# Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)

> **NCT00092092** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 71 (actual)

## Conditions studied

- Asthma, Bronchial

## Interventions

- **DRUG:** Montelukast chewable tablets
- **DRUG:** Budesonide inhaler
- **DRUG:** Placebo to montelukast chewable tablets
- **DRUG:** Placebo to budesonide inhaler

## Key facts

- **NCT ID:** NCT00092092
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092092, "Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00092092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*